Optometrists in Millersburg, PA Accepting Medicare
7 Optometrists found. Showing 1 - 7
 Dr. Erik George Weller, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 670 Rising Sun Ln, Millersburg, PA 17061 Phone: 717-692-2122 Fax: 717-692-4183 |
 Irma Bixler, OD. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 670 Rising Sun Road, Millersburg, PA 17061 Phone: 717-692-2122 Fax: 717-692-4183 |
Dr. Steven Shehan, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 670 Rising Sun Rd, Millersburg, PA 17061 Phone: 717-692-2122 |
 Rising Sun Eye Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 670 Rising Sun Ln, Millersburg, PA 17061 Phone: 717-692-2122 Fax: 717-692-4183 |
Dr. Nicholas S Bixler, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 670 Rising Sun Rd, Rising Sun Eyecare Associates, Millersburg, PA 17061 Phone: 717-692-2122 Fax: 717-692-4183 |
Rising Sun Eyecare Associates Optometrist Medicare: Medicare Enrolled Practice Location: 670 Rising Sun Rd, Millersburg, PA 17061 Phone: 717-692-2122 Fax: 717-692-4183 |
Dr. Steven Carroll Weller, O.D. Optometrist - Corneal and Contact Management Medicare: Accepting Medicare Assignments Practice Location: 670 Rising Sun Ln, Millersburg, PA 17061 Phone: 717-692-2122 Fax: 717-692-4183 |
News Archive
Research sheds light on prenatal heart formation, chromosome 22q.11 deletion syndrome
Researchers studying the common genetic disorder chromosome 22q.11 deletion syndrome have identified key proteins that act together to regulate early embryonic development. One protein is essential to life; in animal studies, embryos without the protein do not survive past the first few days of gestation.
VIA Pharmaceuticals to discuss its cardio-metabolic product portfolio at the Target 2009 conference
VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic diseases, today announced that Dr. Rebecca Taub, Senior Vice President Research & Development will present "Liver Directed Beta Agonist for Targeting Cardiometabolic Disease", and will discuss the Company's cardio-metabolic product portfolio, including VIA's inhibitor of 5 Lipoxygenase, its THR Beta Agonist, and its DGAT1 development programs, at the Cambridge Healthtech Institute Seventh International Discovery on Target 2009 program, on November 3, 2009 in Boston, MA.
IUPUI researcher awarded $1.1 million grant to develop tools to improve care for chronic pain patients
An Indiana University-Purdue University Indianapolis researcher has been awarded $1.1 million to develop information-based tools to help primary care providers improve care for patients with chronic pain, a condition that affects 100 million Americans at a cost of $630 billion annually in health care costs and lost worker productivity.
Decisions people make after being diagnosed with major health issue may lead to higher health risks
It may seem counter-intuitive to take health advice from a marketing professor, but when it comes to analyzing consumer data and its relationship to managing health issues such as diabetes, one University of Alberta researcher may have the right prescription.
› Verified 7 days ago
Physical Therapists
Optometrists
Occupational Therapists
Chiropractors
Podiatrists
Speech-Language Pathologists